What SOTHEMA does

SOTHEMA is a Moroccan pharmaceutical manufacturer founded in 1976 and headquartered in Bouskoura, Morocco. The company develops, manufactures, and distributes pharmaceutical products and describes itself as Morocco's leading pharmaceutical company, operating with a workforce of between 1,001 and 5,000 employees. Its commercial footprint extends across Morocco, sub-Saharan Africa, and the Middle East through its own proprietary distribution network, and the company is publicly listed (cas:SOT). Core business activity is industrial production of medicines, with stated therapeutic focus areas including mental health and women's well-being. The company's distribution network, regulatory licensing, and long-established manufacturing base constitute its primary commercial assets and the basis of its regional market position.

Sothema's revenue model is anchored in one-time sales of manufactured pharmaceutical products distributed through its own channels across its three operating regions. The company supplements its own portfolio by serving as an industrial and distribution platform for partner brands. In February 2026, Sothema signed a memorandum of understanding with Naali at the Officine Expo in Marrakech to market and distribute saffron-based dietary supplements targeting mental health and women's well-being segments. This is consistent with a stated therapeutic diversification strategy that extends the company beyond traditional prescription pharmaceuticals into consumer health adjacencies. In July 2025, Sothema acquired Soludia Maghreb, signaling an active inorganic growth posture. Go-to-market is primarily enterprise field sales through its own distribution network, with selective partnership development at industry events.

No specific pricing models, contract structures, or customer logos are publicly disclosed, and the company does not present an AI, software, or digital health product surface. The business is a conventional branded-generic pharmaceutical manufacturer whose competitive positioning rests on industrial scale, regulatory licensing, distribution reach, and brand longevity rather than technology differentiation.

Name

SOTHEMA

Legal name

Sothema

Website

https://sothema.com

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

SOTHEMA is Morocco's leading pharmaceutical manufacturer, founded in 1976, producing and distributing medicines across Morocco, sub-Saharan Africa, and the Middle East through its own industrial and distribution platform.

Ownership category

akta.pro rank

Headquarters

HQ city

Bouskoura

HQ country

Morocco

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Manufacturing and Distribution: Sothema operates as a leading pharmaceutical company in Morocco, manufacturing and distributing pharmaceutical products across Morocco, sub-Saharan Africa, and the Middle East. The company generates revenue through the production and sale of pharmaceutical products and is expanding into dietary supplements through strategic partnerships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

SOTHEMA manufactures and distributes pharmaceutical products for therapeutic use across Morocco, sub-Saharan Africa, and the Middle East. The company operates industrial-scale drug manufacturing facilities and an extensive proprietary distribution network, and is expanding into saffron-based dietary supplements through a strategic partnership with Naali to address mental health and women's well-being segments.

Product overview

SOTHEMA is Morocco's leading pharmaceutical company founded in 1976, operating as a manufacturer and distributor of pharmaceutical products. The company leverages industrial capabilities and an extensive distribution network spanning Morocco, sub-Saharan Africa, and the Middle East. Through a strategic partnership with Naali (established in 2020), Sothema has expanded into dietary supplements, specifically saffron-based products targeting mental health and women's well-being. The partnership supports Sothema's therapeutic diversification strategy.

Differentiator

Problem solved

Functional benefit

Products and services

• Sothema Pharmaceutical Products Morocco's leading portfolio of manufactured pharmaceutical products covering multiple therapeutic areas, distributed across Morocco, sub-Saharan Africa, and the Middle East through SOTHEMA's proprietary distribution network. Targeted at pharmaceutical wholesalers, pharmacy chains, hospitals, and institutional healthcare providers.
• Naali Saffron-Based Dietary Supplements Saffron-based dietary supplements focused on mental health and women's well-being, manufactured by Naali and distributed through SOTHEMA's pharmaceutical-grade industrial capabilities and regional distribution network following the 2026 partnership. Targeted at health-conscious consumers and wellness retail channels in Morocco and international markets.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• NaalicoreStrategic or Co-development Partner · 1 January 2026Sothema signed a memorandum of understanding with Naali at the 2026 Officine Expo in Marrakech to market Naali's saffron-based dietary supplements across Morocco and internationally. The partnership leverages Sothema's industrial capabilities and distribution network spanning Morocco, sub-Saharan Africa, and the Middle East to expand Naali's products focused on mental health and women's well-being. This agreement supports Sothema's therapeutic diversification strategy while providing Naali with structured growth avenues and broader market access.

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Market position

Weaknesses5 records

Competitive moat4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SOTHEMA